The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Vavilov V.V.

MNPTsDK Departament zdravookhraneniia Moskvy;
Pervyĭ MGMU im. I.M. Sechenova

Clinical features of skin fibrosing disorders

Authors:

Potekaev N.N., Vavilov V.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2013;11(2): 4‑10

Views: 25702

Downloaded: 303

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Potekaev NN, Vavilov VV. Clinical features of skin fibrosing disorders. Russian Journal of Clinical Dermatology and Venereology. 2013;11(2):4‑10. (In Russ.)

 
МСФ на ЯМ
Close metadata
Recommended articles:
Methods of pancreatic fibrosis asse­ssment. Russian Journal of Evidence-Based Gastroenterology. 2024;(1):48-57
Pharmacological prevention of fibrosis in dacryosurgery. Russian Annals of Ophthalmology. 2024;(2-2):180-189
Pathological changes in the muscular tissue of the colon in dive­rticular disease. Russian Journal of Archive of Pathology. 2024;(4):13-22
Coro­nary microvascular dysfunction in rheumatic diseases — what do we know today?. Russian Journal of Preventive Medi­cine. 2024;(9):138-143
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14

Fibrosing skin disorders are characterised by fibrosis, involving dermis and sometimes underlying soft tissues and include wide variety of conditions. This group of disorders can be of unknown origin or can develop under the exposure of different external factors. The article reads about clinical features of different disorders, accompanied by skin fibrosis.

Keywords:

morphea
fibrosis
systemic sclerosis

Authors:

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Vavilov V.V.

MNPTsDK Departament zdravookhraneniia Moskvy;
Pervyĭ MGMU im. I.M. Sechenova

List of references:

  1. Peterson L.S., Nelson A.M., Su W.P. Classification of morphoea (localized scleroderma). Mayo Clin Proc 1995; 70: 1068-1076.
  2. Tuffanelli D.L., Winkelmann R.K. Systemic scleroderma. Arch Dermatol 1955; 84: 359-371.
  3. Zulian F., Martini G. Preliminary classification criteria for juvenile systemic sclerosis. In: Proceedings of the II Workshop on Nomenclature and Diagnostic Criteria for Juvenile Scleroderma Syndromes; 3-6 June 2004; Padua. Eds. F. Zulian, N. Ruperto. Padua: Associazione II Volo 2005; 5-16.
  4. Laxer R.M., Zulian F. Localized scleroderma. Curr Opin Rheumatol 2006; 18: 6: 606-613.
  5. Jacobson L., Palazij R., Jaworsky C. Superficial morphoea. J Am Acad Dermatol 2003; 49: 323-325.
  6. Sawamura D., Yaguchi T., Hashimoto I., Nomura K., Konta R., Umeki K. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. J Dermatol 1998; 25: 6: 409-411.
  7. Farrell A.M., Marren P.M., Wojnarowska F. Genital lichen sclerosus associated with morphoea or systemic sclerosus: clinical and HLA characteristics. Br J Dermatol 2000; 143: 598-603.
  8. Daoud M.S., Su W.P., Leiferman K.M., Perniciaro C. Bullous morphea: clinical, pathologic, an immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994; 30: 6: 937-943.
  9. Trattner A., David M., Sandbank M. Bullous morphea: a distinct entity? Am J Dermatopathol 1994; 16: 414-417.
  10. Labandeira J., Leon-Mateos A., Suarez-Penaranda J.M., Garea M.T., Toribio J. What is nodular-keloidal scleroderma? Dermatology 2003; 207: 2: 130-132.
  11. Larregue M., Ziegler J.E., Lauret P., Bonafe J., Lorette G., Titi A., Ramdenee P., Bressieux J.M. Sclerodermie en bande chez l'enfant (a propos de 27 cas). Ann Dermatol Venereol 1986; 113: 3: 207-224.
  12. Weill J., Dubois M., Lewin., Depondt. Sclerodermie en bandes et atrophies tissulaires multiples. Bull Mem Soc Med Hop Paris 1953; 69: 17-18: 490-495.
  13. Soma Y., Fujimoto M. Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines. J Am Acad Dermatol 1998; 38: 2: Pt 2: 366-368.
  14. Weibel L., Harper J.I. Linear morphoea follows Blaschko's lines. Br J Dermatol 2008; 159: 1: 175-181.
  15. Bramley P., Forbes A. A case of progressive hemiatrophy presenting with spontaneous fractures of the lower jaw. Br Med J 1960; 1: 1476-1478.
  16. Tajima S., Suzuki Y., Inazumi T. A case of atypical localized scleroderma presenting with pseudoainhum: treatment with tranilast, an anti-fibrotic agent. Acta Derm Venereol (Stockh) 1996; 76: 162.
  17. Diaz-Perez J.L., Connolly S.M., Winkelmann R.K. Disabling pansclerotic morphoea of children. Arch Dermatol 1980; 116: 169-173.
  18. Maragh S.H., Davis M.D.P., Bruce A.J., Nelson A.M. Disabling pansclerotic morphea: clinical presentation in two adults. J Am Acad Dermatol 2005; 53: 2: Suppl 1: S115-S119.
  19. Rowell N.R. Acral pansclerotic morphoea with intractable pain. In: Clinical Dermatology: the CMO Case Collection/World Congress of Dermatology. Eds. W.H.C. Burgdorf, S.I. Katz. Berlin: Scheltauer 1987; 178-180.
  20. Wollina U., Buslau M., Weyers W. Squamous cell carcinoma in pansclerotic morphea of childhood. Pediatr Dermatol 2002; 19: 151-154.
  21. Wollina U., Buslau M., Heinig B., Petrov I., Unger E., Kyriopoulou E., Koch A., Köstler E., Schönlebe J., Haroske G., Doede T., Pramatarov K. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma. Int J Low Extrem Wounds 2007; 6: 4: 291-298.
  22. Tollefson M.M., Witman P.M. En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 2007; 56: 2: 257-263.
  23. Rai R., Handa S., Gupta S., Kumar B. Bilateral en coup de sabre: a rare entity. Pediatr Dermatol 2000; 17: 3: 222-224.
  24. Soma Y., Fujimoto M. Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines. J Am Acad Dermatol 1998; 38: 2: Pt 2: 366-368.
  25. Serup J., Serup L., Sjo O. Localized scleroderma 'en coup de sabre' with external eye muscle involvement at the same time. Clin Exp Dermatol 1984; 9: 196-200.
  26. Jappe U., Holzle E., Ring J. Parry-Romberg syndrom Zussamenfassung und neue Erkenntnisse anlablich einer ungewhnlichen Kasuistik. Hautarzt 1996; 47: 599-603.
  27. Azad J., Dawn G., Shaffrali F.C., Holmes S.C., Barnetson R.J., Forsyth A. Does solitary morphoea profundus progress? Clin Exp Dermatol 2004; 29: 1: 25-27.
  28. Sato S., Fujimoto M., Ihn H., Kikuchi K., Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 1994; 31: 567-571.
  29. Christianson H.B., Dorsey E.S., O'Leary P.A., Kierland R. Localized scleroderma: a clinical study of 235 cases. Arch Dermatol 1956; 74: 629-639.
  30. Preliminary criteria for the clas- sification of systemic sclerosis. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-590.
  31. Rustin M.H., Bull H.A., Ziegler V. et al. Silica exposure and silica associated systemic sclerosis. Br J Dermatol 1989; 121: Suppl 34: 29.
  32. Arga J. Systemic sclerosis: an update. Bull NYU Hosp Jt Dis 2008; 66: 3: 198-202.
  33. Chung L., Lin J., Furst D.E., Fiorentino D. Systemic and localized scleroderma. Clin Dermatol 2006; 24: 374-392.
  34. Gupta R.A., Fiorentino D. Localized scleroderma and systemic sclerosis: is there a connection? Best Pract Res Clin Rheumatol 2007; 21: 1025-1036.
  35. Korn J.H., Mayes M., Matucci Cerinic M., Rainisio M., Pope J., Hachulla E., Rich E., Carpentier P., Molitor J., Seibold J.R., Hsu V., Guillevin L., Chatterjee S., Peter H.H., Coppock J., Herrick A., Merkel P.A., Simms R., Denton C.P., Furst D., Nguyen N., Gaitonde M., Black C. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthr Rheum 2004; 50: 12: 3985-3993.
  36. Zulian F. Systemic manifestations in localized scleroderma. Curr Rheumatol Rep 2004; 6: 6: 41-424.
  37. Petrozzi J.W., Wood M.G., Tisa V. Palmar-plantar lichen sclerosus et atrophicus. Arch Dermatol 1979; 115: 7: 884.
  38. Choi S.W., Yang J.E., Park H.J., Kim C.W. A case of extragenital lichen sclerosus following Blaschko's lines. J Am Acad Dermatol 2000; 43: 5: Pt 2: 903-904.
  39. Di Silverio A., Serri F. Generalized bullous and haemorrhagic lichen sclerosus et atrophicus. Br J Dermatol 1975; 93: 215-217.
  40. Janovski N.A., Ames S. Lichen sclerosus et atrophicus of the vulva. Obstet Gynecol 1963; 22: 697-708.
  41. Tasker G.L., Wojnarowska F. Lichen sclerosus. Clin Exp Dermatol 2003; 28: 128-133.
  42. Powell J., Wojnarowska F., Winsey S., Marren P., Welsh K. Lichen sclerosus premenarche: autoimmunity and immunogenetics. Br J Dermatol 2000; 142: 3: 481-484.
  43. Meyrick Thomas R.H., Ridley C.M., Black M.M. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol 1983; 109: 6: 661-664.
  44. Barbagli G., Palminteri E., Balo S., Vallasciani S., Mearini E., Costantini E., Mearini L., Zucchi A., Vivacqua C., Porena M. Lichen sclerosus of the male genitalia and urethral stricture diseases. Urol Int 2004; 73: 1: 1-5.
  45. Kencka D., Blaszczyk M., Jablonska S. Atrophoderma Pasini-Pierini is a primary atrophic abortive morphea. Dermatology 1995; 190: 3: 203-206.
  46. Buechner S.A., Rufli T. Atrophoderma of Pasini and Pierini. Clinical and histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four patients. J Am Acad Dermatol 1994; 30: 3: 441-446.
  47. Yokoyama Y., Akimoto S., Ishikawa O. Disaccharide analysis of skin glycosaminoglycans in atrophoderma of Pasini and Pierini. Clin Exp Dermatol 2000; 25: 5: 436-440.
  48. Saleh Z., Abbas O., Dahdah M.J., Kibbi A.G., Zaynoun S., Ghosn S. Atrophoderma of Pasini and Pierini: a clinical and histopathological study. J Cutan Pathol 2008; 35: 12: 1108-1114.
  49. Lakhampal S., Ginsberg W.W., Michet C.J., Doyle J.A., Moore S.B. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988; 17: 4: 221-231.
  50. Antic M., Lautenschlager S., Itin P.H. Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature. Dermatology 2006; 213: 93-101.
  51. Lebeaux D., Francès C., Barete S., Wechsler B., Dubourg O., Renoux J., Maisonobe T., Benveniste O., Gatfossé M., Bourgeois P., Amoura Z., Cacoub P., Piette J.C., Sène D. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 2012; 51: 3: 557-561.
  52. Cowper S.E., Robin H.S., Steinberg S.M., Su L.D., Gupta S., LeBoit P.E. Scleromyxoedema-like cutaneous diseases in renal dialysis patients. Lancet 2000; 356: 1000-1001.
  53. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104-1108.
  54. Lim Y.L., Lee H.Y., Low S.C., Chan L.P., Goh N.S., Pang S.M. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature. Clin Exp Dermatol 2007; 32: 4: 353-358.
  55. Burgdorf W.H., Worret W.I., Schultka O. Acrodermatitis chronica atrophicans. Int J Dermatol 1979; 18: 8: 595-601.
  56. Stanek G., Strle F. Lyme borreliosis. Lancet 2003; 362: 1639-1647.
  57. Wilson P.R. Porphyria cutanea tarda with cutaneous "scleroderma" and calcification. Australas J Dermatol 1989; 30: 93-96.
  58. Jablonska S., Stachow A. Scleroderma-like lesions in phenylketonuria. In: Jablonska S., ed. Scleroderma and Pseudoscleroderma. Warsaw: Polish Med Publ 1975; 489-498.
  59. Ostlere L.S., Harris D., Buckley C., Black C., Rustin M.H. Atypical systemic sclerosis following exposure to vinyl chloride monomer. A case report and review of the cutaneous aspects of vinyl chloride disease. Clin Exp Dermatol 1992; 17: 3: 208-210.
  60. Hinnen U., Schmid-Grendelmeier P., Muller E. Losungsmittelexposition bei Sklerodermie: disseminierte zirkumskripte Sklerodermie (Morphea) bei einem Perchlorethylen-exponierten Lackierer. Schweiz Med Wochenschr 1995; 125: 2433-2437.
  61. Flindt-Hansen H., Isager H. Scleroderma after occupational exposure to trichlor-ethylene and trichlorethane. Acta Dermatol Venereol 1987; 67: 3: 263-264.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.